  Pleurotus ostreatus is a common cultivated edible mushroom worldwide. The
fruiting bodies of P. ostreatus is a rich source of a $\beta$-glucans
polysaccharide. The current study aimed to investigate the effectiveness of
$\beta$-glucans as a natural polysaccharide produced by P. ostreatus as an
antioxidant, antimicrobial, and anticancer. The molecular identification of P.
ostreatus isolate was confirmed by Internal Transcribed Spacer (ITS) sequence.
The sequence alignment and phylogenetic evolutionary relationship of studied
ITS sequence were performed against some deposited sequences in GenBank. The
analysis of high-performance liquid chromatography (HPLC) as well as the result
of fourier transform infrared spectroscopy (FTIR) has confirmed the presence of
$\beta$-glucans polysaccharide in the tested samples. The percentage of
antioxidant activity of $\beta$-glucans showed a gradual increase from 8.59% to
12.36, 18.56, 23.69, 44.66 and 80.36% at the concentrations of 31.2, 64.4, 125,
250, 500, and 800 $\mu$g/ml, respectively. In addition, all concentrations of
$\beta$-glucans showed higher antioxidant activities when compared with
standard antioxidant (Vitamin C). The highest antimicrobial activity of
$\beta$-glucans polysaccharide was against P. aeruginosa with a zone of
inhibition (45 mm), while the lowest activity was against S. aureus (13 mm)
both at 100 mg/mL. The percentage of growth-inhibiting of MCF-7 a humanbreast
cancer cell line and normal WRL-68 cell line affected by $\beta$-glucans were
determined by 3-(4,5)-dimethylthiazol (-z-y1)-3,5-di-phenytetrazoliumromide
(MTT assay).
